Aileron Therapeutics, Inc. Receives $10,000,000 New Funding Round

  • Feed Type
  • Date
    4/15/2008
  • Company Name
    Aileron Therapeutics, Inc.
  • Mailing Address
    840 Memorial Drive Cambridge, MA 02139
  • Company Description
    Aileron Therapeutics is an emerging biopharmaceutical company that is applying its proprietary cell permeable peptide technology to generate breakthrough therapeutics
    for the treatment of cancer and other diseases. Aileron’s technology is the first and
    only process that allows peptides to penetrate cells in a sequence-independent manner. Aileron is developing the first generation of peptide therapeutics directed at intra-cellular protein-protein interaction targets that are not addressable by small molecule or biological drugs.
  • Website
    http://www.aileronrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    AILERON plans to use the proceeds from this financing to expand its drug discovery team and to open a 10,000+ square foot “Stapled Peptide” research facility located at 840 Memorial Drive in Cambridge, Massachusetts.
  • M&A Terms
  • Venture Investor
    Apple Tree Partners
  • Venture Investor
    Novartis BioVenture Fund

By posting a comment, you agree to our terms and conditions.